PT  - JOURNAL ARTICLE
AU  - Zhao, Jun
AU  - Yu, Xinmin
AU  - Huang, Dingzhi
AU  - Ma, Zhiyong
AU  - Gao, Bo
AU  - Cui, Jiuwei
AU  - Chu, Qian
AU  - Zhou, Qing
AU  - Sun, Meili
AU  - Day, Daphne
AU  - Wu, Jingxun
AU  - Pan, Hongming
AU  - Wang, Lifeng
AU  - Voskoboynik, Mark
AU  - Wang, Zhehai
AU  - Liu, Yunpeng
AU  - Li, Hui
AU  - Zhang, Juan
AU  - Peng, Yanyan
AU  - Wu, Yi-Long
TI  - SAFFRON-103: a phase 1b study of the safety and efficacy of sitravatinib combined with tislelizumab in patients with locally advanced or metastatic non-small cell lung cancer
AID  - 10.1136/jitc-2022-006055
DP  - 2023 Feb 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - e006055
VI  - 11
IP  - 2
4099  - http://jitc.bmj.com/content/11/2/e006055.short
4100  - http://jitc.bmj.com/content/11/2/e006055.full
SO  - J Immunother Cancer2023 Feb 01; 11
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.